Treating cancer with a known T2DM drug: Acarbose suppresses the expression of RNA polymerase I via down regulation of its target gene, 25/February/2015, 5.51 am

Mechanistic insights into tumor suppression: Ribosomal protein L11 increases the expression of tumor suppressor INK4a/p16 via down regulation of its target gene, 25/February/2015, 5.46 am
February 25, 2015
MiRNA-based therapy for p53-mutated human tumors: MiRNA-708 increases the expression of tumor suppressor p53 homologue TAp63γ and inhibits tumorigenesis via down regulation of its target gene, 25/February/2015, 7.23 am
February 25, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Treating cancer with a known T2DM drug: Acarbose  suppresses the expression of RNA polymerase I via down regulation of its target gene, 25/February/2015, 5.51 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: This study suggests, for the first time, that Acarbose, by increasing the expression of  its target gene, it may decrease the expression of RNA polymerase I. Thereby, it may inhibit the proliferation of cancer cells. Thus, pharmacological formulations encompassing “Acarbose or its analogues”  can be used to inhibit the progression of human cancers. 

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Undisclosed information: How Acarbose suppresses the expression of RNA polymerase I

Amount: $ 300

Comments are closed.